Emergent BioSolutions (EBS) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $0.91.
- Emergent BioSolutions' EPS (Weighted Average and Diluted) fell 5582.52% to $0.91 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.31, marking a year-over-year increase of 13250.62%. This contributed to the annual value of -$3.6 for FY2024, which is 7578.3% up from last year.
- Emergent BioSolutions' EPS (Weighted Average and Diluted) amounted to $0.91 in Q3 2025, which was down 5582.52% from -$0.22 recorded in Q2 2025.
- Over the past 5 years, Emergent BioSolutions' EPS (Weighted Average and Diluted) peaked at $3.29 during Q4 2021, and registered a low of -$5.38 during Q2 2024.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.9, with a median of -$0.59 in 2024.
- Per our database at Business Quant, Emergent BioSolutions' EPS (Weighted Average and Diluted) skyrocketed by 61250.0% in 2021 and then tumbled by 1050000.0% in 2022.
- Emergent BioSolutions' EPS (Weighted Average and Diluted) (Quarter) stood at $3.29 in 2021, then tumbled by 140.67% to -$1.34 in 2022, then skyrocketed by 34.2% to -$0.88 in 2023, then soared by 32.89% to -$0.59 in 2024, then soared by 254.09% to $0.91 in 2025.
- Its last three reported values are $0.91 in Q3 2025, -$0.22 for Q2 2025, and $1.19 during Q1 2025.